Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race | Zendy

Priya Bhagwat | Zendy; Ighovwerha Ofotokun | Zendy; Grace A. McComsey | Zendy; Todd T. Brown | Zendy; Carlee Moser | Zendy; Catherine A. Sugar | Zendy; Judith S. Currier | Zendy

Open Access

Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race

Author(s) -

Priya Bhagwat,

Ighovwerha Ofotokun,

Grace A. McComsey,

Todd T. Brown,

Carlee Moser,

Catherine A. Sugar,

Judith S. Currier

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofy201

Subject(s) - raltegravir , medicine , darunavir , waist , ritonavir , regimen , atazanavir , population , viral load , human immunodeficiency virus (hiv) , surgery , body mass index , antiretroviral therapy , immunology , environmental health

With antiretroviral therapy initiation, higher WC increases in the RAL arm compared with PIs were more pronounced in female and black participants, and a more advanced baseline HIV disease state was a strong predictor of larger abdominal increases. Understanding factors predisposing individuals to abdominal fat gain could inform health management after therapy initiation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research